3rd Quarter - Report — MAYO CLINIC for MAYO CLINIC (2016)

Firm

MAYO CLINIC

Client

MAYO CLINIC

Income

—

Expenses

$250,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Hospital Payments, Physician Payments, Healthcare Grants, Stark/anti-trust, Telemedicine, LDTs, HIPAA

Lobbyist	Covered position, as disclosed
JENNIFER MALLARD	Director, Federal Government Relations

Contacted: Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); White House Office; Vice President of the U.S.; HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Medicare/Medicaid MMM

Medicare physician payments; Medicare hospital payments; Medicare clinical lab payments; Teaching hospital payments; ACOs; CMMI; Quality Issues; Telemedicine; Drug Pricing.

Lobbyist	Covered position, as disclosed
JENNIFER MALLARD	Director, Federal Government Relations

Contacted: HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Vice President of the U.S.; Natl Institutes of Health (NIH); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); White House Office; SENATE

Medical/Disease Research/Clinical Labs MED

Lab Payments; Lab Oversight; Research Funding; Precision Medicine; Cancer Moonshot

Lobbyist	Covered position, as disclosed
JENNIFER MALLARD	Director, Federal Government Relations

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Vice President of the U.S.; White House Office; Centers For Disease Control & Prevention (CDC); Natl Institutes of Health (NIH)

Science/Technology SCI

Telemedicine; Medical Device Technologies; New Diagnostic Tests; Precision Medicine; Cancer Moonshot

Lobbyist	Covered position, as disclosed
JENNIFER MALLARD	—

Contacted: Vice President of the U.S.; SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Natl Institutes of Health (NIH); White House Office; Centers For Disease Control & Prevention (CDC)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.